{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:17:36Z","timestamp":1778905056501,"version":"3.51.4"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10787-026-02225-2","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:12:57Z","timestamp":1775538777000},"page":"3153-3164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Auranofin reimagined: an emerging therapeutic candidate for neurodegenerative diseases through molecular mechanistic insights"],"prefix":"10.1007","volume":"34","author":[{"given":"Kanika","family":"Vashisht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amardeep","family":"Ankalgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendra Singh","family":"Ashawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3692-2774","authenticated-orcid":false,"given":"Shiv Kumar","family":"Kushawaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"1","key":"2225_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12672-021-00439-0","volume":"12","author":"FH Abdalbari","year":"2021","unstructured":"Abdalbari FH, Telleria CM (2021) The gold complex auranofin: new perspectives for cancer therapy. Discover Oncol 12(1):42. https:\/\/doi.org\/10.1007\/s12672-021-00439-0","journal-title":"Discover Oncol"},{"issue":"4","key":"2225_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.31083\/j.jin2204081","volume":"22","author":"P Abdul-Muneer","year":"2023","unstructured":"Abdul-Muneer P (2023) Nrf2 as a potential therapeutic target for traumatic brain injury. J Integr Neurosci 22(4):81. https:\/\/doi.org\/10.31083\/j.jin2204081","journal-title":"Journal of Integr Neurosci"},{"issue":"1","key":"2225_CR3","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.1038\/s41598-020-64882-9","volume":"10","author":"NS Abutaleb","year":"2020","unstructured":"Abutaleb NS, Seleem MN (2020) Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection. Sci Rep 10(1):7701. https:\/\/doi.org\/10.1038\/s41598-020-64882-9","journal-title":"Sci Rep"},{"issue":"9","key":"2225_CR4","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1093\/jac\/dkv163","volume":"70","author":"L Aguinagalde","year":"2015","unstructured":"Aguinagalde L et al (2015) Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections. J Antimicrob Chemother 70(9):2608\u20132617. https:\/\/doi.org\/10.1093\/jac\/dkv163","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"2225_CR5","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3390\/biomedicines11092502","volume":"11","author":"LA Al-Kharashi","year":"2023","unstructured":"Al-Kharashi LA et al (2023) Auranofin modulates thioredoxin reductase\/Nrf2 signaling in peripheral immune cells and the CNS in a mouse model of relapsing\u2013remitting EAE. Biomedicines 11(9):2502","journal-title":"Biomedicines"},{"key":"2225_CR6","unstructured":"Ata BN (2022) Live cell imaging of redox mediated Nrf2 activity using transcription factor based biosensors and chemogenetic tools"},{"issue":"2","key":"2225_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1134\/S1819712421020045","volume":"15","author":"I Babkina","year":"2021","unstructured":"Babkina I, Sergeeva S, Gorbacheva L (2021) The role of NF-\u03baB in neuroinflammation. Neurochemical J 15(2):114\u2013128","journal-title":"Neurochemical J"},{"issue":"1","key":"2225_CR8","first-page":"37","volume":"89","author":"JA Borovac","year":"2016","unstructured":"Borovac JA (2016) Side effects of a dopamine agonist therapy for Parkinson\u2019s disease: a mini-review of clinical pharmacology. Yale J Biol Med 89(1):37","journal-title":"Yale J Biol Med"},{"issue":"8","key":"2225_CR9","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/molecules30081726","volume":"30","author":"P Checconi","year":"2025","unstructured":"Checconi P et al (2025) Searching for new gold (I)-based complexes as anticancer and\/or antiviral agents. Molecules 30(8):1726. https:\/\/doi.org\/10.3390\/molecules30081726","journal-title":"Molecules"},{"key":"2225_CR10","volume-title":"p38 Mitogen-activated protein kinase inhibition in castration-resistant prostate cancer","author":"S Cheung","year":"2020","unstructured":"Cheung S (2020) p38 Mitogen-activated protein kinase inhibition in castration-resistant prostate cancer. University of Toronto, Canada"},{"issue":"5","key":"2225_CR11","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3390\/ijms26052084","volume":"26","author":"N Chmelyuk","year":"2025","unstructured":"Chmelyuk N et al (2025) Inhibition of thioredoxin-reductase by auranofin as a pro-oxidant anticancer strategy for glioblastoma: in vitro and in vivo studies. Int J Mol Sci 26(5):2084. https:\/\/doi.org\/10.3390\/ijms26052084","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2225_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jsr.2012.08.011","volume":"43","author":"VG Coronado","year":"2012","unstructured":"Coronado VG et al (2012) Trends in traumatic brain injury in the US and the public health response: 1995\u20132009. J Saf Res 43(4):299\u2013307. https:\/\/doi.org\/10.1016\/j.jsr.2012.08.011","journal-title":"J Saf Res"},{"issue":"7","key":"2225_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/antibiotics13070652","volume":"13","author":"F Coscione","year":"2024","unstructured":"Coscione F et al (2024) The many lives of auranofin: how an old anti-rheumatic agent may become a promising antimicrobial drug. Antibiotics 13(7):652. https:\/\/doi.org\/10.3390\/antibiotics13070652","journal-title":"Antibiotics"},{"key":"2225_CR14","first-page":"272","volume":"5","author":"J Cummings","year":"2019","unstructured":"Cummings J, Lee G, Ritter A, Sabbag M, Zhong K (2019) Alzheimer\u2019s disease drug development pipeline: 2019. Alzheimer\u2019s Dement Transl Res Clin Interv 5:272\u2013293","journal-title":"Alzheimer\u2019s Dementia: Translational Res Clin Interventions"},{"key":"2225_CR15","first-page":"1","volume":"55","author":"D Dalal","year":"2025","unstructured":"Dalal D, Singh L, Singh A (2025) Desmethylglycitein attenuates scopolamine-induced cognitive deficits via Nrf-2 activation and IL-1\u03b2 suppression. Neurophysiology 55:1\u201310","journal-title":"Neurophysiology"},{"key":"2225_CR16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5455\/jcmr.2023.14.02.17","volume":"14","author":"P Das","year":"2023","unstructured":"Das P, Singh R, Kumar A (2023) Current scenario and recent advances in neurological disorders. J Complement Med Res 14:110\u2013121","journal-title":"J Complement Med Res"},{"issue":"8","key":"2225_CR17","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3390\/cells10081884","volume":"10","author":"DA Davies","year":"2021","unstructured":"Davies DA, Adlimoghaddam A, Albensi BC (2021) Role of Nrf2 in synaptic plasticity and memory in Alzheimer\u2019s disease. Cells 10(8):1884. https:\/\/doi.org\/10.3390\/cells10081884","journal-title":"Cells"},{"issue":"45","key":"2225_CR18","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1039\/d0dt02478c","volume":"49","author":"RE de Paiva","year":"2020","unstructured":"de Paiva RE et al (2020) What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks. Dalton Trans 49(45):16004\u201316033. https:\/\/doi.org\/10.1039\/d0dt02478c","journal-title":"Dalton Trans"},{"issue":"1","key":"2225_CR20","doi-asserted-by":"publisher","first-page":"e3903","DOI":"10.1002\/cbf.3903","volume":"42","author":"N Deepika","year":"2024","unstructured":"Deepika N, Rajendra PN, Radhiga T (2024) Auranofin sensitizes breast cancer cells to paclitaxel-mediated cell death via regulating FOXO3\/Nrf2\/Keap1 signaling pathway. Cell Biochem Funct 42(1):e3903. https:\/\/doi.org\/10.1002\/cbf.3903","journal-title":"Cell Biochem Funct"},{"issue":"5","key":"2225_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10534-025-00712-7","volume":"38","author":"Deepika","year":"2025","unstructured":"Deepika et al (2025) Crosstalk between copper, Alzheimer\u2019s disease, and melatonin. Biometals 38(5):1\u201340. https:\/\/doi.org\/10.1007\/s10534-025-00712-7","journal-title":"Biometals"},{"issue":"2","key":"2225_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10787-007-7007-6","volume":"16","author":"A Dhir","year":"2008","unstructured":"Dhir A, Akula K, Kulkarni S (2008) Rofecoxib potentiates the anticonvulsant effect of topiramate. Inflammopharmacology 16(2):83\u201386. https:\/\/doi.org\/10.1007\/s10787-007-7007-6","journal-title":"Inflammopharmacology"},{"issue":"1","key":"2225_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X et al (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Therapy 8(1):73","journal-title":"Signal Transduct Target Therapy"},{"issue":"12","key":"2225_CR23","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1523\/JNEUROSCI.4371-06.2007","volume":"27","author":"R Fan","year":"2007","unstructured":"Fan R et al (2007) Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J Neurosci 27(12):3057\u20133063. https:\/\/doi.org\/10.1523\/JNEUROSCI.4371-06.2007","journal-title":"J Neurosci"},{"issue":"4","key":"2225_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/BF00914097","volume":"14","author":"H Friedman","year":"1990","unstructured":"Friedman H et al (1990) Auranofin-induced suppression of autoimmune antibody production and inflammation in genetically autoimmune-prone mice. Inflammation 14(4):463\u2013470. https:\/\/doi.org\/10.1007\/BF00914097","journal-title":"Inflammation"},{"issue":"5","key":"2225_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/j.1875-9114.1983.tb03277.x","volume":"3","author":"DE Furst","year":"1983","unstructured":"Furst DE (1983) Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin: an orally administered organic gold compound for the treatment of rheumatoid arthritis. Pharmacother J Hum Pharmacol Drug Therapy 3(5):284\u2013296","journal-title":"Pharmacotherapy: J Hum Pharmacol Drug Therapy"},{"key":"2225_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/BF00914097","volume":"115","author":"Y Fuse","year":"2018","unstructured":"Fuse Y et al (2018) The possible repositioning of an oral anti-arthritic drug, auranofin, for Nrf2-activating therapy: the demonstration of Nrf2-dependent anti-oxidative action using a zebrafish model. Free Radic Biol Med 115:405\u2013411. https:\/\/doi.org\/10.1007\/BF00914097","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"2225_CR27","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/med.21872","volume":"42","author":"T Gamberi","year":"2022","unstructured":"Gamberi T et al (2022) Upgrade of an old drug: auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness. Med Res Rev 42(3):1111\u20131146. https:\/\/doi.org\/10.1002\/med.21872","journal-title":"Med Res Rev"},{"key":"2225_CR28","doi-asserted-by":"crossref","unstructured":"Gencheva R (2024) Mechanisms of action of thioredoxin reductase inhibitors in the context of cancer. Karolinska Institutet","DOI":"10.69622\/26893846.v1"},{"issue":"2","key":"2225_CR29","first-page":"e1966","volume":"7","author":"R Gencheva","year":"2024","unstructured":"Gencheva R et al (2024) Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting. Cancer Rep, 7(2), e1966","journal-title":"Cancer Rep"},{"key":"2225_CR30","doi-asserted-by":"publisher","first-page":"1431423","DOI":"10.3389\/fcell.2024.1431423","volume":"12","author":"J Guo","year":"2024","unstructured":"Guo J et al (2024) Evaluation of the effect of GSK-3\u03b2 on liver cancer based on the PI3K\/AKT pathway. Front Cell Dev Biol 12:1431423. https:\/\/doi.org\/10.3389\/fcell.2024.1431423","journal-title":"Front cell Dev biology"},{"key":"2225_CR31","doi-asserted-by":"crossref","unstructured":"Gupta A, Sharma B (2025) Neurodegenerative diseases (ND): an introduction. Synaptic plasticity in neurodegenerative disorders. CRC Press, pp 3\u201320","DOI":"10.1201\/9781003464648-2"},{"issue":"1","key":"2225_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12272-008-1122-9","volume":"31","author":"S Han","year":"2008","unstructured":"Han S et al (2008) Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages. Arch Pharm Res 31(1):67\u201374. https:\/\/doi.org\/10.1007\/s12272-008-1122-9","journal-title":"Arch Pharm Res"},{"issue":"7","key":"2225_CR33","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","volume":"52","author":"T Hanada","year":"2011","unstructured":"Hanada T et al (2011) Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia 52(7):1331\u20131340","journal-title":"Epilepsia"},{"key":"2225_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biopha.2018.10.088","volume":"109","author":"EH Hassanein","year":"2019","unstructured":"Hassanein EH et al (2019) The impact of Keap1\/Nrf2, P38MAPK\/NF-\u03baB and Bax\/Bcl2\/caspase-3 signaling pathways in the protective effects of berberine against methotrexate-induced nephrotoxicity. Biomed Pharmacother 109:47\u201356. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.088","journal-title":"Biomed Pharmacother"},{"key":"2225_CR35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/ard.48.2.134","volume":"48","author":"T Herlin","year":"1989","unstructured":"Herlin T (1989) Auranofin: pharmacodynamics update from issue 459. Ann Rheumat1c D1seases 48:134","journal-title":"Annals Rheumat1c D1seases"},{"issue":"6","key":"2225_CR36","doi-asserted-by":"publisher","first-page":"C1310","DOI":"10.1152\/ajpcell.00573.2008","volume":"296","author":"W Hu","year":"2009","unstructured":"Hu W, Li F, Mahavadi S, Murthy KS (2009) Upregulation of RGS4 expression by IL-1\u03b2 in colonic smooth muscle is enhanced by ERK1\/2 and p38 MAPK and inhibited by the PI3K\/Akt\/GSK3\u03b2 pathway. Am J Physiology-Cell Physiol 296(6):C1310\u2013C1320. https:\/\/doi.org\/10.1152\/ajpcell.00573.2008","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"11","key":"2225_CR37","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.3390\/ijms22115920","volume":"22","author":"H Hwangbo","year":"2021","unstructured":"Hwangbo H et al (2021) Anti-inflammatory effect of auranofin on palmitic acid and LPS-induced inflammatory response by modulating TLR4 and NOX4-mediated NF-\u03baB signaling pathway in RAW264. 7 macrophages. Int J Mol Sci 22(11):5920","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2225_CR39","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/antiox10101628","volume":"10","author":"M Jazvin\u0161\u0107ak Jembrek","year":"2021","unstructured":"Jazvin\u0161\u0107ak Jembrek M, Or\u0161oli\u0107 N, Mandi\u0107 L, Sad\u017eak A, \u0160egota S (2021) Anti-oxidative, anti-inflammatory and anti-apoptotic effects of flavonols: targeting Nrf2, NF-\u03baB and p53 pathways in neurodegeneration. Antioxidants 10(10):1628","journal-title":"Antioxidants"},{"issue":"8","key":"2225_CR38","doi-asserted-by":"publisher","first-page":"6888","DOI":"10.3390\/ijms24086888","volume":"24","author":"M Jazvin\u0161\u0107ak Jembrek","year":"2023","unstructured":"Jazvin\u0161\u0107ak Jembrek M, Or\u0161oli\u0107 N, Karlovi\u0107 D, Peitl V (2023) Flavonols in action: targeting oxidative stress and neuroinflammation in major depressive disorder. Int J Mol Sci 24(8):6888","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2225_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0028-3908(01)00148-4","volume":"42","author":"M Jeub","year":"2002","unstructured":"Jeub M et al (2002) Effect of phenytoin on sodium and calcium currents in hippocampal CA1 neurons of phenytoin-resistant kindled rats. Neuropharmacology 42(1):107\u2013116. https:\/\/doi.org\/10.1016\/s0028-3908(01)00148-4","journal-title":"Neuropharmacology"},{"issue":"4","key":"2225_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/ars.2022.0079","volume":"38","author":"J Jia","year":"2023","unstructured":"Jia J, Xu G, Zhu D, Liu H, Zeng X, Li L (2023) Advances in the functions of thioredoxin system in central nervous system diseases. Antioxid Redox Signal 38(4):425\u2013441","journal-title":"Antioxid Redox Signal"},{"key":"2225_CR43","doi-asserted-by":"publisher","first-page":"100682","DOI":"10.37349\/en.2025.100682","volume":"4","author":"M Kaur","year":"2025","unstructured":"Kaur M, Singh S, Singh A, Singh A (2025) Mechanisms of action of formononetin, an extract from Astragalus membranaceus medicinal plant, in ameliorating Alzheimer\u2019s disease. Explor Neurosci 4:100682. https:\/\/doi.org\/10.37349\/en.2025.100682","journal-title":"Explor Neurosci"},{"issue":"3","key":"2225_CR44","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1254\/jphs.09330FP","volume":"113","author":"NH Kim","year":"2010","unstructured":"Kim NH, Oh MK, Park HJ, Kim IS (2010) Auranofin, a gold (I)-containing antirheumatic compound, activates Keap1\/Nrf2 signaling via Rac1\/iNOS signal and mitogen-activated protein kinase activation. J Pharmacol Sci 113(3):246\u2013254","journal-title":"J Pharmacol Sci"},{"issue":"12","key":"2225_CR46","doi-asserted-by":"publisher","first-page":"10031","DOI":"10.1007\/s00210-024-03253-x","volume":"397","author":"SK Kushawaha","year":"2024","unstructured":"Kushawaha SK, Ashawat MS, Baldi A (2024a) Auranofin-loaded PLGA nanoparticles alleviate cognitive deficit induced by streptozotocin in rats model: modulation of oxidative stress, neuroinflammatory markers, and neurotransmitters. Naunyn Schmiedebergs Arch Pharmacol 397(12):10031\u201310047. https:\/\/doi.org\/10.1007\/s00210-024-03253-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"2225_CR47","doi-asserted-by":"publisher","first-page":"756","DOI":"10.52711\/0974-360X.2024.00118","volume":"17","author":"SK Kushawaha","year":"2024","unstructured":"Kushawaha SK, Ashawat MS, Baldi A (2024b) Neuroprotective effect of aurothioglucose-loaded PLGA nanoparticles in an aluminum chloride-induced rat model of Alzheimer\u2019s disease. Res J Pharm Technol 17(2):756\u2013762","journal-title":"Research J Pharm Technol"},{"key":"2225_CR48","doi-asserted-by":"publisher","first-page":"148906","DOI":"10.1016\/j.brainres.2024.148906","volume":"1834","author":"SK Kushawaha","year":"2024","unstructured":"Kushawaha SK et al (2024c) Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer\u2019s disease. Brain Res 1834:148906. https:\/\/doi.org\/10.1016\/j.brainres.2024.148906","journal-title":"Brain Res"},{"issue":"17","key":"2225_CR45","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.2174\/0113816128336703241202182209","volume":"31","author":"SK Kushawaha","year":"2025","unstructured":"Kushawaha SK, Ashawat MS, Arora R, Baldi A (2025) Auranofin-loaded PLGA nanoparticles for neuroprotection against aluminium-induced Alzheimer\u2019s disease. Curr Pharm Des 31(17):1402\u20131415. https:\/\/doi.org\/10.2174\/0113816128336703241202182209","journal-title":"Curr Pharm Design"},{"key":"2225_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1528-1157.43.s.6.11.x","volume":"43","author":"M Leonardi","year":"2002","unstructured":"Leonardi M, Ustun TB (2002) The global burden of epilepsy. Epilepsia 43:21\u201325","journal-title":"Epilepsia"},{"issue":"6","key":"2225_CR50","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1158\/0008-5472.CAN-13-1729","volume":"74","author":"A Lin","year":"2014","unstructured":"Lin A et al (2014a) FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K\u2013AKT pathway. Cancer Res 74(6):1682\u20131693. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1729","journal-title":"Cancer Res"},{"issue":"5","key":"2225_CR51","doi-asserted-by":"publisher","first-page":"9705","DOI":"10.1007\/s11357-014-9705-5","volume":"36","author":"CH Lin","year":"2014","unstructured":"Lin CH et al (2014b) Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3K\/Akt signaling to improve the effects of exercise in elderly rat hearts. Age 36(5):9705","journal-title":"Age"},{"issue":"2","key":"2225_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0301-0082(03)00005-4","volume":"69","author":"AK Liou","year":"2003","unstructured":"Liou AK et al (2003) To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog Neurobiol 69(2):103\u2013142","journal-title":"Prog Neurobiol"},{"issue":"1","key":"2225_CR54","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/antiox12010172","volume":"12","author":"Z Liu","year":"2023","unstructured":"Liu Z et al (2023) Is nuclear factor erythroid 2-related factor 2 a target for the intervention of cytokine storms? Antioxidants 12(1):172. https:\/\/doi.org\/10.3390\/antiox12010172","journal-title":"Antioxidants"},{"key":"2225_CR53","doi-asserted-by":"publisher","unstructured":"Liu H, Yang N, Wang Y, Li T, Lu R (2025) Precision design of ferritin nanocages: tumor-targeted delivery, multi-mechanism synergistic therapy and clinical translational challenges. Drug Development and Industrial Pharmacy (just-accepted), 1\u201326. https:\/\/doi.org\/10.1080\/03639045.2025.2582684","DOI":"10.1080\/03639045.2025.2582684"},{"key":"2225_CR55","doi-asserted-by":"publisher","first-page":"648636","DOI":"10.3389\/fphar.2021.648636","volume":"12","author":"HZ Long","year":"2021","unstructured":"Long HZ et al (2021) PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease. Front Pharmacol 12:648636","journal-title":"Front Pharmacol"},{"issue":"22","key":"2225_CR56","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.lfs.2013.04.005","volume":"92","author":"J Madeira","year":"2013","unstructured":"Madeira J et al (2013) Novel protective properties of auranofin: inhibition of human astrocyte cytotoxic secretions and direct neuroprotection. Life Sci 92(22):1072\u20131080. https:\/\/doi.org\/10.1016\/j.lfs.2013.04.005","journal-title":"Life Sci"},{"issue":"19","key":"2225_CR57","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1016\/0006-2952(89)90638-2","volume":"38","author":"CW Mahoney","year":"1989","unstructured":"Mahoney CW, Hensey CE, Azzi A (1989) Auranofin, gold thiomalate, and gold thioglucose inhibit protein kinase C. Biochem Pharmacol 38(19):3383\u20133386","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"2225_CR58","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1097\/00006123-200106000-00051","volume":"48","author":"ROS Mejia","year":"2001","unstructured":"Mejia ROS, Ona VO, Li M, Friedlander RM (2001) Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48(6):1393\u20131401. https:\/\/doi.org\/10.1097\/00006123-200106000-00051","journal-title":"Neurosurgery"},{"issue":"1","key":"2225_CR59","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12974-023-02923-6","volume":"20","author":"S Meng","year":"2023","unstructured":"Meng S et al (2023) ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood\u2013brain barrier integrity after traumatic brain injury. J Neuroinflamm 20(1):244","journal-title":"J Neuroinflamm"},{"issue":"7","key":"2225_CR60","doi-asserted-by":"publisher","first-page":"e21967","DOI":"10.1002\/syn.21967","volume":"71","author":"A Migdalska-Richards","year":"2017","unstructured":"Migdalska-Richards A, Ko WKD, Li Q, Bezard E, Schapira AH (2017) Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate. Synapse 71(7):e21967. https:\/\/doi.org\/10.1002\/syn.21967","journal-title":"Synapse"},{"key":"2225_CR61","unstructured":"Miri SM (2024) Revisiting the impact of H2o2 on intracellular Nrf2 levels us\u0131ng a newly developed oxygen-independent Nrf2 b\u0131osensor. Thesis, Sabanci University"},{"issue":"9","key":"2225_CR62","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12032-023-02124-4","volume":"40","author":"AG Mukherjee","year":"2023","unstructured":"Mukherjee AG, Gopalakrishnan AV (2023) The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario. Med Oncol 40(9):248. https:\/\/doi.org\/10.1007\/s12032-023-02124-4","journal-title":"Med Oncol"},{"issue":"7","key":"2225_CR63","first-page":"827","volume":"25","author":"S Nabi","year":"2022","unstructured":"Nabi S, Bhandari U, Haque SE (2022) Saroglitazar ameliorates monosodium glutamate-induced obesity and associated inflammation in Wistar rats: plausible role of NLRP3 inflammasome and NF-\u03baB. Iran J Basic Med Sci 25(7):827","journal-title":"Iran J Basic Med Sci"},{"issue":"12","key":"2225_CR64","doi-asserted-by":"publisher","first-page":"567","DOI":"10.5483\/bmbrep.2013.46.12.248","volume":"46","author":"KJ Oh","year":"2013","unstructured":"Oh KJ, Han HS, Kim MJ, Koo SH (2013) CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis. BMB Rep 46(12):567. https:\/\/doi.org\/10.5483\/bmbrep.2013.46.12.248","journal-title":"BMB Rep"},{"key":"2225_CR65","doi-asserted-by":"publisher","first-page":"776847","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou Z et al (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Health 9:776847","journal-title":"Front Public Health"},{"issue":"8","key":"2225_CR66","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.bcp.2009.04.034","volume":"78","author":"M Oz","year":"2009","unstructured":"Oz M, Lorke DE, Petroianu GA (2009) Methylene blue and Alzheimer\u2019s disease. Biochem Pharmacol 78(8):927\u2013932","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2225_CR67","first-page":"1","volume":"67","author":"ML Pall","year":"2015","unstructured":"Pall ML, Levine S (2015) Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanisms, is raised by health-promoting factors. Acta Physiol Sinica 67(1):1\u201318","journal-title":"Acta Physiol Sinica"},{"issue":"5","key":"2225_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2174\/1570193X13666160728121823","volume":"13","author":"KV Parin","year":"2016","unstructured":"Parin KV, Rakesh RS, Madhuri HJ (2016) Drug repositioning: an approach for drug discovery. Mini-Rev Org Chem 13(5):363\u2013376. https:\/\/doi.org\/10.2174\/1570193X13666160728121823","journal-title":"Mini-Rev Org Chem"},{"issue":"3","key":"2225_CR68","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/neuroglia403","volume":"4","author":"MB Pasula","year":"2023","unstructured":"Pasula MB et al (2023) Glucose transporter-2 regulation of male versus female hypothalamic astrocyte MAPK expression and activation: Impact of glucose. Neuroglia 4(3):158\u2013171. https:\/\/doi.org\/10.3390\/neuroglia403","journal-title":"Neuroglia"},{"key":"2225_CR69","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.neuroscience.2014.07.046","volume":"277","author":"SP Patil","year":"2014","unstructured":"Patil SP, Jain P, Ghumatkar P, Tambe R, Sathaye S (2014) Neuroprotective effect of metformin in MPTP-induced Parkinson\u2019s disease in mice. Neuroscience 277:747\u2013754","journal-title":"Neuroscience"},{"issue":"5","key":"2225_CR70","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1021\/acs.inorgchem.9b03072","volume":"59","author":"IJ Pickering","year":"2020","unstructured":"Pickering IJ et al (2020) Direct observation of methylmercury and auranofin binding to selenocysteine in thioredoxin reductase. Inorg Chem 59(5):2711\u20132718. https:\/\/doi.org\/10.1021\/acs.inorgchem.9b03072","journal-title":"Inorg Chem"},{"issue":"17","key":"2225_CR71","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.3390\/molecules26175327","volume":"26","author":"MH Rahman","year":"2021","unstructured":"Rahman MH et al (2021) Therapeutic potential of natural products in treating neurodegenerative disorders and their future prospects and challenges. Molecules 26(17):5327","journal-title":"Molecules"},{"issue":"14","key":"2225_CR72","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","volume":"348","author":"B Reisberg","year":"2003","unstructured":"Reisberg B et al (2003) Memantine in moderate-to-severe Alzheimer\u2019s disease. N Engl J Med 348(14):1333\u20131341. https:\/\/doi.org\/10.1056\/NEJMoa013128","journal-title":"N Engl J Med"},{"issue":"1","key":"2225_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/00207450212018","volume":"112","author":"DG Richards","year":"2002","unstructured":"Richards DG, McMILLIN DL, Mein EA, Nelson CD (2002) Gold and its relationship to neurological\/glandular conditions. Int J Neurosci 112(1):31\u201353","journal-title":"Int J Neurosci"},{"issue":"2","key":"2225_CR74","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/cells10020262","volume":"10","author":"I Rippin","year":"2021","unstructured":"Rippin I, Eldar-Finkelman H (2021) Mechanisms and therapeutic implications of GSK-3 in treating neurodegeneration. Cells 10(2):262","journal-title":"Cells"},{"issue":"1","key":"2225_CR75","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","volume":"15","author":"C Roder","year":"2015","unstructured":"Roder C, Thomson MJ (2015) Auranofin: repurposing an old drug for a golden new age. Drugs R D 15(1):13\u201320","journal-title":"Drugs R D"},{"issue":"12","key":"2225_CR76","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3390\/cells12121671","volume":"12","author":"T Roy","year":"2023","unstructured":"Roy T et al (2023) The PI3K-Akt-mTOR and associated signaling pathways as molecular drivers of immune-mediated inflammatory skin diseases: update on therapeutic strategy using natural and synthetic compounds. Cells 12(12):1671","journal-title":"Cells"},{"issue":"4","key":"2225_CR77","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3233\/JAD-2012-111661","volume":"30","author":"JL Searcy","year":"2012","unstructured":"Searcy JL et al (2012) Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer\u2019s disease. J Alzheimer\u2019s disease 30(4):943\u2013961. https:\/\/doi.org\/10.3233\/JAD-2012-111661","journal-title":"J Alzheimer\u2019s disease"},{"issue":"7","key":"2225_CR78","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12032-022-01693-0","volume":"39","author":"SH Shahcheraghi","year":"2022","unstructured":"Shahcheraghi SH et al (2022) The role of NRF2\/KEAP1 pathway in glioblastoma: pharmacological implications. Med Oncol 39(7):91","journal-title":"Med Oncol"},{"issue":"4","key":"2225_CR79","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1002\/jcp.29219","volume":"235","author":"P Shaw","year":"2020","unstructured":"Shaw P, Chattopadhyay A (2020) Nrf2\u2013ARE signaling in cellular protection: Mechanism of action and the regulatory mechanisms. J Cell Physiol 235(4):3119\u20133130. https:\/\/doi.org\/10.1002\/jcp.29219","journal-title":"J Cell Physiol"},{"key":"2225_CR80","doi-asserted-by":"crossref","unstructured":"Simard JM (2014) Glyburide-novel prophylaxis and effective treatment for traumatic brain injury","DOI":"10.21236\/ADA610917"},{"issue":"10","key":"2225_CR82","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","volume":"18","author":"S Singh","year":"2020","unstructured":"Singh S, Singh TG (2020) Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: an mechanistic approach. Curr Neuropharmacol 18(10):918\u2013935. https:\/\/doi.org\/10.2174\/1570159X18666200207120949","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"2225_CR81","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s11011-025-01615-9","volume":"40","author":"A Singh","year":"2025","unstructured":"Singh A, Singh L, Dalal D (2025) Neuroprotective potential of Hispidulin and diosmin: a review of molecular mechanisms. Metab Brain Dis 40(5):188. https:\/\/doi.org\/10.1007\/s11011-025-01615-9","journal-title":"Metab Brain Dis"},{"key":"2225_CR83","doi-asserted-by":"publisher","first-page":"177523","DOI":"10.1016\/j.ejphar.2025.177523","volume":"998","author":"D Soni","year":"2025","unstructured":"Soni D et al (2025) Auranofin-loaded chitosan-lipid hybrid nanoparticle protects against rotenone model of Parkinson\u2019s disease via modulation of GSK-3\u03b2\/Nrf2\/HO-1 signaling. Eur J Pharmacol 998:177523. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177523","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"2225_CR84","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3390\/life11121437","volume":"11","author":"G Stati","year":"2021","unstructured":"Stati G et al (2021) The role of the CREB protein family members and the related transcription factors in radioresistance mechanisms. Life 11(12):1437","journal-title":"Life"},{"issue":"1","key":"2225_CR85","doi-asserted-by":"publisher","first-page":"572192","DOI":"10.53730\/ijhs.v5n1.2864","volume":"5","author":"IW Suryasa","year":"2021","unstructured":"Suryasa IW, Rodr\u00edguez-G\u00e1mez M, Koldoris T (2021) Health and treatment of diabetes mellitus. Int J health Sci 5(1):572192","journal-title":"Int J health Sci"},{"issue":"6","key":"2225_CR86","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/ph15060692","volume":"15","author":"S Suzen","year":"2022","unstructured":"Suzen S et al (2022) A pivotal role of Nrf2 in neurodegenerative disorders: a new way for therapeutic strategies. Pharmaceuticals 15(6):692","journal-title":"Pharmaceuticals"},{"key":"2225_CR87","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fonc.2017.00085","volume":"7","author":"K Taguchi","year":"2017","unstructured":"Taguchi K, Yamamoto M (2017) The KEAP1\u2013NRF2 system in cancer. Front Oncol 7:85. https:\/\/doi.org\/10.3389\/fonc.2017.00085","journal-title":"Front Oncol"},{"issue":"1","key":"2225_CR88","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/cancers13010046","volume":"13","author":"K Taguchi","year":"2020","unstructured":"Taguchi K, Yamamoto M (2020) The KEAP1\u2013NRF2 system as a molecular target of cancer treatment. Cancers 13(1):46. https:\/\/doi.org\/10.3390\/cancers13010046","journal-title":"Cancers"},{"key":"2225_CR89","doi-asserted-by":"crossref","unstructured":"Taylor CA (2017) Traumatic brain injury\u2013related emergency department visits, hospitalizations, and deaths\u2014United States, 2007 and 2013. MMWR, p 66","DOI":"10.15585\/mmwr.ss6609a1"},{"issue":"9","key":"2225_CR90","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/ejn.14307","volume":"49","author":"J Tehse","year":"2019","unstructured":"Tehse J, Taghibiglou C (2019) The overlooked aspect of excitotoxicity: glutamate-independent excitotoxicity in traumatic brain injuries. Eur J Neurosci 49(9):1157\u20131170","journal-title":"Eur J Neurosci"},{"issue":"10","key":"2225_CR91","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1007\/s11010-025-05330-y","volume":"480","author":"D Thakur","year":"2025","unstructured":"Thakur D et al (2025) Updated insights on ASK1 signaling: mechanisms, regulation, and therapeutic potential in diseases. Mol Cell Biochem 480(10):5267\u20135296. https:\/\/doi.org\/10.1007\/s11010-025-05330-y","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"2225_CR92","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.4155\/fmc-2018-0544","volume":"11","author":"N Tharmalingam","year":"2019","unstructured":"Tharmalingam N et al (2019) Auranofin is an effective agent against clinical isolates of Staphylococcus aureus. Future Med Chem 11(12):1417\u20131425","journal-title":"Future Med Chem"},{"key":"2225_CR93","doi-asserted-by":"publisher","first-page":"314082","DOI":"10.4061\/2011\/314082","volume":"20111","author":"K Tufekci U","year":"2011","unstructured":"Tufekci K U, Civi Bayin E, Genc S, Genc K (2011) The Nrf2\/ARE pathway: a promising target to counteract mitochondrial dysfunction in Parkinson\u2019s disease. Parkinson\u2019s disease 20111:314082. https:\/\/doi.org\/10.4061\/2011\/314082","journal-title":"Parkinson\u2019s disease"},{"issue":"7","key":"2225_CR94","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/antiox10071069","volume":"10","author":"TF Villavicencio","year":"2021","unstructured":"Villavicencio TF, Quintanilla RA (2021) Contribution of the Nrf2 pathway on oxidative damage and mitochondrial failure in Parkinson\u2019s and Alzheimer\u2019s disease. Antioxidants 10(7):1069","journal-title":"Antioxidants"},{"issue":"11","key":"2225_CR95","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1089\/ars.2010.3211","volume":"13","author":"N Villeneuve","year":"2010","unstructured":"Villeneuve N, Lau A, Zhang DD (2010) Regulation of the Nrf2\u2013Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxid Redox Signal 13(11):1699\u20131712. https:\/\/doi.org\/10.1089\/ars.2010.3211","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"2225_CR96","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s11033-021-06896-8","volume":"49","author":"S Vishwakarma","year":"2022","unstructured":"Vishwakarma S, Singh S, Singh TG (2022) Pharmacological modulation of cytokines correlating neuroinflammatory cascades in epileptogenesis. Mol Biol Rep 49(2):1437\u20131452","journal-title":"Mol Biol Rep"},{"issue":"5","key":"2225_CR97","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","volume":"195","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier CF et al (2017) Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med 195(5):557\u2013582","journal-title":"Am J Respir Crit Care Med"},{"key":"2225_CR150","doi-asserted-by":"crossref","unstructured":"Vora PK et al (2016) Drug repositioning: an approach for drug discovery. Mini-Rev Org Chem 13(5):363\u2013376","DOI":"10.2174\/1570193X13666160728121823"},{"issue":"5","key":"2225_CR98","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/antiox10050632","volume":"10","author":"SB Wall","year":"2021","unstructured":"Wall SB et al (2021) Auranofin-mediated NRF2 induction attenuates interleukin 1 beta expression in alveolar macrophages. Antioxidants 10(5):632. https:\/\/doi.org\/10.3390\/antiox10050632","journal-title":"Antioxidants"},{"issue":"9","key":"2225_CR99","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3390\/molecules29092005","volume":"29","author":"H Wang","year":"2024","unstructured":"Wang H, Han J, Dmitrii G, Zhang XA (2024) Potential targets of natural products for improving cardiac ischemic injury: the role of Nrf2 signaling transduction. Molecules, 29(9), p 2005. https:\/\/doi.org\/10.3390\/molecules29092005","journal-title":"Molecules"},{"key":"2225_CR100","doi-asserted-by":"publisher","unstructured":"Wilson M (2023) Constructing measures: an item response modeling approach. 2nd edn. New York, Routledge, p. 394. https:\/\/doi.org\/10.4324\/9781003286929","DOI":"10.4324\/9781003286929"},{"key":"2225_CR102","doi-asserted-by":"publisher","first-page":"108272","DOI":"10.1016\/j.intimp.2021.108272","volume":"101","author":"M Yamashita","year":"2021","unstructured":"Yamashita M (2021) Auranofin: past to present, and repurposing. Int Immunopharmacol 101:108272. https:\/\/doi.org\/10.1016\/j.intimp.2021.108272","journal-title":"Int Immunopharmacol"},{"key":"2225_CR101","doi-asserted-by":"publisher","first-page":"20250002","DOI":"10.2490\/prm.20250002","volume":"10","author":"H Yamashita","year":"2025","unstructured":"Yamashita H et al (2025) Therapeutic intervention for trunk control impairments in central nervous system disorders: a comprehensive review of methods and efficacy. Prog Rehabil Med 10:20250002. https:\/\/doi.org\/10.2490\/prm.20250002","journal-title":"Progress Rehabilitation Med"},{"issue":"30","key":"2225_CR103","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.2174\/1568026616666160530181328","volume":"16","author":"H Ye","year":"2016","unstructured":"Ye H, Wei J, Tang K, Feuers R, Hong H (2016) Drug repositioning through network pharmacology. Curr Top Med Chem 16(30):3646\u20133656","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"2225_CR104","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.nbd.2005.08.011","volume":"21","author":"JH Yon","year":"2006","unstructured":"Yon JH, Carter LB, Reiter RJ, Jevtovic-Todorovic V (2006) Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis 21(3):522\u2013530","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"2225_CR105","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/jnr.20350","volume":"79","author":"MB Youdim","year":"2005","unstructured":"Youdim MB et al (2005) Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition. J Neurosci Res 79(1\u20132):172\u2013179. https:\/\/doi.org\/10.1002\/jnr.20350","journal-title":"J Neurosci Res"},{"issue":"3","key":"2225_CR106","first-page":"155","volume":"14","author":"A Yousaf","year":"2025","unstructured":"Yousaf A, Kabir F, Dalal D, Singh A (2025) Role of calycosin (a derivative of formononetin) in Parkinson\u2019s disease. Lett Appl Nanobiosci 14(3):155","journal-title":"Lett Appl Nanobiosci"},{"key":"2225_CR107","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2017.11.015","volume":"339","author":"Y Zhang","year":"2018","unstructured":"Zhang Y et al (2018) Diabetes mellitus and Alzheimer\u2019s disease: GSK-3\u03b2 as a potential link. Behav Brain Res 339:57\u201365. https:\/\/doi.org\/10.1016\/j.bbr.2017.11.015","journal-title":"Behav Brain Res"},{"issue":"2","key":"2225_CR108","doi-asserted-by":"publisher","first-page":"L155","DOI":"10.1152\/ajplung.00449.2016","volume":"312","author":"H Zhao","year":"2017","unstructured":"Zhao H, Eguchi S, Alam A, Ma D (2017) The role of nuclear factor-erythroid 2 related factor 2 (Nrf-2) in the protection against lung injury. Am J Physiology-Lung Cell Mol Physiol 312(2):L155\u2013L162. https:\/\/doi.org\/10.1152\/ajplung.00449.2016","journal-title":"Am J Physiology-Lung Cell Mol Physiol"},{"issue":"5","key":"2225_CR109","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s10495-023-01824-6","volume":"28","author":"N Zhao","year":"2023","unstructured":"Zhao N, Gao Y, Jia H, Jiang X (2023) Anti-apoptosis effect of traditional Chinese medicine in the treatment of cerebral ischemia\u2013reperfusion injury. Apoptosis 28(5):702\u2013729. https:\/\/doi.org\/10.1007\/s10495-023-01824-6","journal-title":"Apoptosis"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02225-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02225-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02225-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:00:26Z","timestamp":1778904026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02225-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2225"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02225-2","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}